SINOTHERAPEUTICS INC.

Autres langues Sinotherapeutics Inc.

Actions

688247

CNE100005PL9

Cours en clôture Shanghai S.E. Autres places de cotation 00:00:00 04/06/2024			Varia. 5j.	Varia. 1 janv.
8,83 ^CNY	-0,79%		-2,00%	-19,58%

29/04	Sinotherapeutics Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI
23/02	Sinotherapeutics Inc. annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI

Autres langues

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Sinotherapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	29/04
Tranche Update on Sinotherapeutics Inc.'s Equity Buyback Plan announced on February 21, 2024.	02/04
Sinotherapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	23/02
Sinotherapeutics Inc. announces an Equity Buyback for CNY 70 million worth of its shares.	21/02
Sinotherapeutics Inc. authorizes a Buyback Plan.	19/02
Sinotherapeutics Gets Nod for Mesalazine Tablets; Shares Drop 7%	05/02
Sinotherapeutics Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023	30/10/23
Sinotherapeutics' Unit Gets Registration Certificate for Sevelamer Carbonate Tablets	26/09/23
Sinotherapeutics Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	29/08/23
Sinotherapeutics Inc.(SHSE:688247) added to Shanghai Stock Exchange A Share Index	25/08/23
Sinotherapeutics Inc.(SHSE:688247) added to Shanghai Stock Exchange Composite Index	25/08/23
Sinotherapeutics Gets US FDA Nod for Arthritis Drug	10/08/23
Sinotherapeutics Signs Product Licensing Deal With US Drugmaker Lannett	07/08/23
FDA Greenlights Sinotherapeutics' Mesalazine Enteric-Coated Tablets	17/05/23
Sinotherapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	27/04/23
Sinotherapeutics Drug Selected in China's Centralized Drug Procurement	13/04/23
Sinotherapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	27/02/23
Sinotherapeutics’ Antifungal Drug Added to China’s Medical Insurance Catalog	19/01/23
Sinotherapeutics Inc. has completed an IPO in the amount of CNY 424.8358 million.	22/08/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

-40% Prolongation exceptionnelle : Nos abonnements vous guident vers les meilleurs investissements de demain.

PROFITEZ-EN MAINTENANT